drugset / Trial / NCT02162407

A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin

NCT02162407

Phase 1 Completed 13 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This study is conducted in Europe. The aim of this study is to estimate the relationship between pharmacodynamic and interstitial pharmacokinetic steady state following intravenous (i.v.) administration of insulin detemir and human soluble insulin.

Timeline

Start
1999-10
Primary completion
1999-12
Completion
1999-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator human soluble insulin Protein / enzyme biologic 6 unknown Intravenous
Subject insulin detemir Protein / enzyme biologic 60 unknown Intravenous
Subject insulin detemir Protein / enzyme biologic 120 unknown Intravenous

Indications